CN1603334A - Process for preparing notoginseng diol saponin - Google Patents

Process for preparing notoginseng diol saponin Download PDF

Info

Publication number
CN1603334A
CN1603334A CN 200410070156 CN200410070156A CN1603334A CN 1603334 A CN1603334 A CN 1603334A CN 200410070156 CN200410070156 CN 200410070156 CN 200410070156 A CN200410070156 A CN 200410070156A CN 1603334 A CN1603334 A CN 1603334A
Authority
CN
China
Prior art keywords
notoginseng
diol saponin
preparation
notoginseng diol
silica gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200410070156
Other languages
Chinese (zh)
Inventor
李明劲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200410070156 priority Critical patent/CN1603334A/en
Publication of CN1603334A publication Critical patent/CN1603334A/en
Priority to CNB2005100750390A priority patent/CN100471865C/en
Pending legal-status Critical Current

Links

Landscapes

  • Steroid Compounds (AREA)

Abstract

This invention discloses a preparation method of notoginseng glycol saponin. Procedures are that notoginseng is crashed, and then it is soaked and percolated by ethanol of 60% concentration. Percolate is collected, decompressed and concentrated, and then the concentrated solution is diluted by distilled water and added to macropore polymeric adsorbent separation column and eluted by 60% ethanol. The eluent is collected and decompressed and concentrated into glycol saponin crude solution, then refining to get the shallow brown yellow powder notoginseng glycol saponin of relative density is 1.10. The content of notoginseng glycol saponin made by This invention discloses high, quality is stable, color is good, and cost is low, safe and available.

Description

The preparation method of notoginseng diol saponin
Invention field
The invention relates to a kind of extracting method of medicinal plant, more particularly about a kind of preparation method who from pseudo-ginseng, extracts notoginseng diol saponin.
Background technology
Pseudo-ginseng always is the good medicine of treatment wound, and this is to be firmly established and widespread use in traditional Chinese medicine.As still using clinically at present, be that the Chinese patent medicine of monarch drug in a prescription has with the pseudo-ginseng: the Yunnan white powder that has won fame both at home and abroad, ginseng seven kinds of impairments medicine, compound cure the wound diffusing, fall and spray Anisodus carniolicoides C.Y.Wu et C.Chen and baiyao or the like.Wherein compound cures the wound and looses and baiyao can control respectively also that the bone network is had a pain and muscles and bones is swollen and ache.
The private power of single medicinal material is special, is Chinese medicine preparation " seven sides' " " odd-numbered prescription ", and pseudo-ginseng also has single method with Herba indigoferae Pseudotinctoriae when the clinical use of tradition.
Notoginseng diol saponin is that the single medicinal material pseudo-ginseng (has another name called pseudo-ginseng, Panax pseudoginseng) saponin extract, be the efficient part of pseudo-ginseng dissipating blood stasis for subsidence of swelling analgesic therapy, except that also containing compositions such as ginsenoside Rg1, Re and arasaponin R1 main containing effective constituent ginsenoside Rb1 that subduing swelling and relieving pain does and the Rd with function of promoting blood circulation to disperse blood clots.
Pseudo-ginseng another name pseudo-ginseng, Panax pseudoginseng are Araliaceae Panax Panaxnotoginseng (Burk) F.H.Chen rhizome, main product in Yunnan, Guangxi.Pseudo-ginseng is one of conventional Chinese medicine, and the main component of its biological activity and pharmacological action is a saponins.The pharmacological results shows that Radix Notoginseng total arasaponins can increase blood flow volume, vasodilation, reduction arteriotony and myocardial consumption of oxygen, improves the human body function and reaches the anoxybiotic tolerance, and effects such as the platelet aggregation of supression, reduction blood viscosity are arranged.
" Chinese pharmacopoeia claims: pseudo-ginseng effect " stasis of blood of loosing hemostasis, subduing swelling and relieving pain ".Compendium of Material Medica claims: Radix Notoginseng " sweet, little hardship, temperature is nontoxic " cures mainly " hemostasis, loose blood, analgesic therapy ".
The sick system of numbness is by plain body deficiency, and healthy tendency is empty partially, interspaces of skin and muscles being loose, and perverse trend invasion and attack such as weakened defensive QI and sense chill the are damp and hot and channels and collaterals resistance is closed, QI-blood circulation is not smooth, so that muscle arthralgia, numbness, is weighing, joint stuffiness and form bi Zheng.Just say " slightly managing and interior not hard person kind sick numbness " as far back as " Ling Shu Miraculous Pivot or Divine Axis five becomes "." all numbness doors of Prescriptions for Succouring the Sick " said: " all because of body void, space between skin and muscles is empty, and the air humidity gas of having a cold forms numbness also ".
Bi Zheng is just sick true, then for a long time vital QI being weakened and pathogen being violent, the time of simulataneous insufficiency and excessive of being more.Three kinds of pathological changes appear in bi Zheng easily: the one, and with the passing of time the damp and hot numbness of chill do not heal, and qi-blood-body fluid is moved not smooth pathology day very, blood-vessel obstructive, the skin ecchymosis appears in body fluid cohesion, so that the turbid resistance numbness of hemostasis phlegm channels and collaterals, tubercle around the joint, arthroncus, diseases such as joint stuffiness.The 2nd, disease makes the qi and blood damage for a long time, presents in various degree deficiency of qi and blood or syndrome such as caused by liver and kidney deficiency.The 3rd, bi Zheng does not heal, and the syndrome of internal organs numbness appears in disease and internal organs by channels and collaterals.Many the imposing respectively according to the damp and hot inclined to one side victory of chill of medical circles dispeled the wind at all times, and it is cold to loose, and dehumidifying is relaxed through the Coryza Treated by Syndrome Differentiation of vein relaxing, is aided with benefit and fills blood, and strengthens the body resistance to consolidate the constitution and reaches the purpose of normal circulation of qi and blood.
Up to now, do not see relevant specialty report with notoginseng diol saponin treatment bi Zheng.
The inventor after years of research and found that, many compositions in the Radix Notoginseng total arasaponins are invalid to the human body therapy bi Zheng, real effective is notoginseng glycol saponin etc., the character of relevant notoginseng glycol saponin, pharmacological action, preparation method and the effect of human body be there is no report.
Summary of the invention
The objective of the invention is to overcome the defective that prior art exists, a kind of method of extracting notoginseng diol saponin from pseudo-ginseng is provided.
Second purpose of the present invention provides a kind of preparation method that can treat the notoginseng diol saponin of bi Zheng.
These and other objects of the present invention will further embody by detailed description below and illustrate.
The preparation method of notoginseng diol saponin of the present invention comprises the following steps:
1, gets pseudo-ginseng and pulverized sieve No. one, add concentration and be 60% alcohol immersion, diacolation, collect percolate;
2, percolate concentrating under reduced pressure reclaims ethanol;
3, concentrated solution dilutes with distilled water, slowly is added in the macroporous adsorbent resin separator column, uses distilled water, 40% ethanol and 60% ethanol elution successively, collects 60% ethanol eluate;
4,60% ethanol eluate is 1.10 diol saponin crude product solution through being evaporated to relative density;
5, the diol saponin crude product solution is admixed silica gel, abundant mixing, and drying under reduced pressure must be mixed sample silica gel;
6, will mix sample silica gel and pack in 23 times of silicagel columns,, check, and collect and contain ginsenoside R with the silica gel G plate with the mixed solvent wash-out that contains vinyl acetic monomer, second alcohol and water B1, R dStream part Deng composition;
7, elutriant filters, and filtrate decompression is concentrated into phase density 1.33 fluid extracts;
8, fluid extract drying under reduced pressure gets dry extract, and dry extract is pulverized, and promptly gets the notoginseng diol saponin of light yellowish brown powder.
Further, in notoginseng diol saponin preparation method of the present invention, its raw material is 10: 1 with the ratio of macroporous adsorbent resin, the post footpath of macroporous adsorbent resin with the ratio of post height is: 30: 160, macroporous adsorbent resin is the styrene type interpolymer, model is D-101, and the macroporous adsorbent resin separator column is good for handling balance.Described concentrating under reduced pressure or drying under reduced pressure temperature are 50 ± 5 ℃
In the preparation method of notoginseng diol saponin of the present invention, also comprise the macroporous adsorbent resin regeneration step, be about to used macroporous adsorbent resin separator column and wash, reduce the alcohol concn wash-out gradually with 1% hydrochloride ethanol liquid, until extremely neutral, can reuse with distilled water flushing.
In the preparation method of notoginseng diol saponin of the present invention, also comprise post layer silica regeneration step, be about to used silica gel, it is colourless to be eluted to effluent liquid with distilled water, takes out the silica gel baking, when oven temperature rises to 120 ± 2 ℃, stop heating, naturally cooling can use.
With notoginseng diol saponin content height, steady quality that method of the present invention is extracted, color and luster is good, will can satisfy the requirement of modernized Chinese medicine fully with its Chinese medicine preparation that is raw material is made, and cost is low, the notoginseng diol saponin loss is few; Compare with traditional solvent extration, do not use toxicity and volatile organic solvent in the technical process, safe and reliable, the production technique of Jian Huaing greatly.
The notoginseng glycol saponin that extracts with method of the present invention has significant increase blood flow volume, vasodilation, reduction arteriotony, improve the human body function and to the anoxybiotic tolerance, restrain platelet aggregation and reduce effects such as blood viscosity, and can treat rheumatisms such as rheumatoid arthritis and rheumatic arthritis.
Below in conjunction with embodiment in detail the present invention is described in detail, can not limits this but embodiment only is used for explanation
Scope of invention.
In the present invention, if not refer in particular to, all part, per-cents are weight unit, and all equipment and starting material etc. all can be buied from market or the industry is commonly used.
Embodiment
Example 1: be prepared according to the following steps:
1, gets 100 gram pseudo-ginseng and pulverized sieve No. one, add concentration and be 60% alcohol immersion, diacolation, the collection percolate;
2, percolate concentrating under reduced pressure, temperature are 50 ℃, reclaim ethanol;
3, concentrated solution is diluted to the 500-600 milliliter with distilled water, (the post footpath with the ratio of post height is: 30: 160 slowly to be added to the macroporous adsorbent resin separator column, in 100 milliliters of D101 resins are housed) in, use 500 ml distilled waters, 1000 milliliter of 40% ethanol and 1000 milliliter of 60% ethanol elution successively, flow velocity be 0.5 times of bed volume/hour, collect 60% ethanol eluate;
4,60% ethanol eluate is 1.10 diol saponin crude product solution through being evaporated to relative density when temperature is 50 ℃;
5, the diol saponin crude product solution is admixed in the silica gel (ordinary method and ratio), abundant mixing, drying under reduced pressure must be mixed sample silica gel;
6, will mix sample silica gel and pack in 23 times of silicagel columns, contain mixed solvent (three's ratio is: 1: 1: the 10) wash-out of vinyl acetic monomer, second alcohol and water, check, and collect and contain ginsenoside R with the silica gel G plate with the 600-800 milliliter B1, R dStream part Deng composition;
7, elutriant filters, and to get relative density be 1.33 fluid extract to concentrating under reduced pressure when filtrate was 50 ℃ in temperature;
8, with the fluid extract drying under reduced pressure, get dry extract, dry extract is pulverized, promptly get about 2.15 grams of notoginseng diol saponin of light yellowish brown powder.
9, macroporous adsorbent resin regeneration: with used macroporous adsorbent resin separator column with 1% acidic alcohol
The liquid flushing reduces the alcohol concn wash-out gradually, until extremely neutral with distilled water flushing;
10, post layer silica regeneration step: with used silica gel, it is colourless to be eluted to effluent liquid with distilled water, takes out the silica gel baking, when oven temperature rises to 120 ± 2 ℃, stops heating, and naturally cooling can use.
Example 1: be prepared according to the following steps:
1, gets 50 gram pseudo-ginseng and pulverized sieve No. one, add concentration and be 60% alcohol immersion, diacolation, the collection percolate;
2, percolate concentrating under reduced pressure, temperature are 50 ℃, reclaim ethanol;
3, concentrated solution is diluted to the 200-300 milliliter with distilled water, (the post footpath with the ratio of post height is: 30: 160 slowly to be added to the macroporous adsorbent resin separator column, in 40 milliliters of D101 resins are housed) in, use 200 ml distilled waters, 300 milliliter of 40% ethanol and 400 milliliter of 60% ethanol elution successively, flow velocity be 0.6 times of bed volume/hour, collect 60% ethanol eluate;
4,60% ethanol eluate is 1.10 diol saponin crude product solution through being evaporated to relative density when temperature is 50 ℃;
5, the diol saponin crude product solution is admixed in the silica gel (ordinary method and ratio), abundant mixing, drying under reduced pressure must be mixed sample silica gel;
6, will mix sample silica gel and pack in 23 times of silicagel columns, contain mixed solvent (three's ratio is: 1: 0.8: the 10) wash-out of vinyl acetic monomer, second alcohol and water, check, and collect and contain ginsenoside R with the silica gel G plate with the 100-300 milliliter B1, R dStream part Deng composition;
7, elutriant filters, and to get relative density be 1.33 fluid extract to concentrating under reduced pressure when filtrate was 50 ℃ in temperature;
8, with the fluid extract drying under reduced pressure, get dry extract, dry extract is pulverized, promptly get about 0.98 gram of notoginseng diol saponin of light yellowish brown powder.
9, macroporous adsorbent resin regeneration: used macroporous adsorbent resin separator column is washed with 1% hydrochloride ethanol liquid, reduce the alcohol concn wash-out gradually, until extremely neutral with distilled water flushing;
10, post layer silica regeneration step: with used silica gel, it is colourless to be eluted to effluent liquid with distilled water, takes out the silica gel baking, when oven temperature rises to 120 ± 2 ℃, stops heating, and naturally cooling can use.
Example 3: the anti-inflammatory of notoginseng diol saponin and the effect of suppression pain
The fallow medicinal powder lot number 940201 that provided by plant chamber, the court by reagent thing notoginseng diol saponin, content R B1=59.15 Rd=15.10%.Be mixed with the solution of desired concn before the test with distilled water, for the laboratory animal gastric infusion.
The Kunming mouse that laboratory animal provides with the court's Animal House production (body weight 19-23g) removes immunity and is male with invigorate blood circulation test and Wistar kind rat (body weight 120-150g)) raise in the observation ward of central air-conditioning is arranged, feed is the full nutrition piece material that central medicine inspecting institute produces, the drink tap water, conformity certification Tianjin moving 001.
INDOMETHACIN is the pulvis that Tianjin pharmacy two factories of central authorities give, and the tragacanth mucilage with 1.0% is mixed with the suspension of 1.0mg/ml concentration, for the laboratory animal gastric infusion.
Test method and result
One, the anti-inflammatory action of notoginseng diol saponin
1,50 male mices is used in this test that influences of mouse dropsy of ear, be divided into 5 groups at random, 10 every group.Every day, gastric infusion was 1 time, successive administration 5 days, and control group administered physiological saline, after the last administration 30 minutes, drip 0.05 milliliter of Oleum Tiglii proinflammatory agent to every mouse left side auricular concha, put to death after 2 hours.Cut left and right sides ear, lay with the position auricle, weigh with 9 millimeters punch tool of diameter, with the difference of two ear weight as mouse dropsy of ear degree.Take the mean and the control group comparison, advance statistical test result (seeing Table 1) and find the notoginseng diol saponin oral administration, to the restraining effect highly significant of mouse dropsy of ear, and have certain dose-effect relationship, its magnitude relation equation y=0.097 x+ 5.629 (r=0.8834)
Table 1 notoginseng diol saponin is to the anti-inflammatory action of mouse dropsy of ear
Figure A20041007015600111
*p<0.05 **P<0.01 ***P<0.001
2,50 male rats, random packet, 10 every group are used in swollen this test that influences to the rat foot.1 successive administration of gastric infusion every day 4 days, control group administered physiological saline.After the last administration 30 minutes, cause inflammation for 0.05 milliliter at left hind foot pad subcutaneous injection 1.0% lrish moss mucilage.Respectively cause scorching before and cause scorching afterwards 30,60,120 and 180 minutes, measure rat with projector (amplifying 6 times) and cause scorching limb (right hind) ankle joint below 0.5 centimeters diameter, with causing difference before and after scorching as swollen account degree, take the mean and control group relatively, carry out statistical test.Result's (seeing Table 2) finds notoginseng diol saponin to the swollen restraining effect highly significant of rat foot, and on this experimental inflammatory model, the anti-inflammatory action of notoginseng diol saponin is not less than the INDOMETHACIN of 5 milligrams of/kilogram dosage.
Table 2 notoginseng diol saponin is to the swollen influence of rat carrageenan foot
Figure A20041007015600121
*p<0.05 **p<0.01 ***p<0.001
3,50 male rats are used in this test that influences of rat assist agent arthritis, be divided into 5 groups at random, 10 every group.The preparation system of adjuvant adds the bacille Calmette-Guerin vaccine of deactivation in advance in the incomplete freund adjuvant of sterilization in advance, grinds the adjuvant that is mixed with 10 mg/ml concentration.The model preparation is adopted at 0.1 milliliter of adjuvant of every right back sufficient pad portion's intradermal injection of rat, induces arthritic generation.
(1) influence to the primary pathology is 200 milligrams/kilogram in causing scorching preceding 4 days beginning dosages, 100 milligrams/kilogram and 50 milligrams/kilogram, and control group physiological saline.Every day, gastric infusion was 1 time, caused inflammation in 30 minutes after the last administration, observed to cause scorching back 18 hours and the 8th day swollen degree of adjuvant injection parapodum.Measure the diameter (amplifying 6 times) of 0.5 centimeters under every rat right hind leg ankle joint with projector, so that the difference before and after scorching is made the swelling degree, take the mean and the control group comparison, carry out statistical test, result's (seeing Table 3) shows the anti-inflammatory action highly significant of notoginseng diol saponin to rat assist agent arthritis primary pathology, and the effect of three dosage all is not less than the INDOMETHACIN of 2.5 milligrams of/kilogram dosage.
(2), to the influence of Secondary cases pathology in adjuvant injection back beginning in the 8th day gastric infusion, dosage is the same, every day 1 time, successive administration to the 30 days, observe the preventive and therapeutic effect of notoginseng diol saponin, from the self administration of medication, every 4-5 days to the Secondary cases pathology, with the left back vola thickness of miking rat (adjuvant injection offside, represent with millimeter), as the index of Secondary cases pathology swelling degree, take the mean and the control group comparison, carry out statistical test, the results are shown among the table.The visible notoginseng diol saponin of result from table to the swollen preventive and therapeutic effect highly significant of parapodum, points out this medicine can stop and alleviate the generation of rat assist agent arthritis Secondary cases pathology to the adjuvant injection.
Table 3 notoginseng diol saponin is to the influence of rat assist agent arthritis primary pathology
Figure A20041007015600131
*p<0.05 **p<0.01 ***p<0.001
(3), the influence to the general pathology removes the swelling degree of observing left back foot (adjuvant injection offside), outside the index as polyarthritis, also observe forelimb, ear and general pathologies such as afterbody pathology incidence and severity, press 0-4 level point system record, the into statistical test of taking the mean, result's (seeing Table 5) finds that notoginseng diol saponin can stop the generation of general pathology equally.
Table 4 notoginseng diol saponin is to the influence of rat assist agent arthritis Secondary cases pathology
Figure A20041007015600141
*p<0.05 **p<0.01 ***p<0.001
Table 5 notoginseng diol saponin is to the influence of rat assist agent arthritis general pathology
*p<0.05 **p<0.01 ***p<0.001
4,50 male rats, random packet, 10 every group are used in swollen this test that influences to rat granuloma.Administration in advance 4 days, every day 1 time, dosage is 200 milligrams/kilogram, 100 milligrams/kilogram and 50 milligrams/kilogram, control rats is given physiological saline.Behind the 4th day gastric infusion 30 minutes, use the etherization rat, at oxter inoculation cotton balls, continued administration then 7 days.Put to death rat in 24 hours after the last administration, peel off granuloma induced by implantation of cotton pellets, claim weight in wet base earlier, the back is dry in 80 degree baking ovens, claims dry weight again, and it is heavy to deduct cotton balls, and it is heavy promptly to get granuloma.Take the mean and the control group comparison, carry out statistical test, result's (seeing Table 6) finds that notoginseng diol saponin is remarkable to the swollen restraining effect of rat granuloma, points out this medicine that chronic inflammatory diseases is also had tangible anti-inflammatory action, the cortisone of the not little 10mg/kg of its action intensity.
Table 6 notoginseng diol saponin is to the swollen influence of rat granuloma
*p<0.05 **p<0.01 ***p<0.001
Two, the analgesic activity of notoginseng diol saponin
1,50 male mices, random packet, 10 every group are used in this test that influences of mouse acetic acid twisting reaction.Every day, gastric infusion was 1 time, successive administration 4 days, and after the last administration 30 minutes, 02 milliliter/mouse of abdominal injection 0.6% acetum was turned round the body number of times with every mouse in second of the register record 10 minutes after 10 minutes.Do physiological saline and INDOMETHACIN control group simultaneously, that calculates every group of mouse on average turns round the body number, relatively carries out statistical test with control group, and result's (seeing Table 7) finds the analgesic activity highly significant of notoginseng diol saponin on this model.
Table 7 notoginseng diol saponin is to the analgesic activity of mouse acetic acid twisting reaction
*p<0.05 **p<0.01 ***p<0.001
2, to mouse water-bath whipping reaction to influence laboratory animal and grouping and administration situation thereof the same, after administration in the 4th day 30,90,120 minutes, respectively 55 ± 0.Measure the mouse whipping response latency in the 5 degree water-baths, as threshold of pain index, take the mean and the control group comparison, carry out statistical test, the visible pseudo-ginseng alcohol of result's (seeing Table 8) saponin oral administration can improve the threshold of pain of mouse water-bath whipping very significantly, and its analgesic activity does not have to surpass the INDOMETHACIN of 5 milligrams of/kilogram dosage.
3,50 male rats are used in this test that influences of rat water-bath whipping reaction, be divided into 5 groups at random, 10 every group.Every day, gastric infusion was 1 time, successive administration 3 days, after the last administration 30,90 and 120 minutes, measure the rat whipping response latency in 55 ± 0.5 degree waters bath with thermostatic control, as threshold of pain index, do physiological saline and INDOMETHACIN control group simultaneously, that calculates every group of rat on average turns round number, relatively carries out statistical test with control group.Result's (seeing Table 9) finds that notoginseng diol saponin also has certain analgesic activity on this model.
Table 8 notoginseng diol saponin is to the analgesic activity of mouse water-bath whipping reaction
*p<0.05 **p<0.01 ***p<0.001
Table 9 notoginseng diol saponin is to the analgesic activity of rat water-bath whipping reaction
*p<0.05 **p<0.01 ***p<0.001
Three, to the influence of the tardy property of mouse contact dermatitis
50 mouse are used in this test, are divided into 5 groups at random, 10 every group.Male and female half and half.Every day, gastric infusion was 1 time, and successive administration 10 days after administration in the 3rd day 30 minutes, is given 20 milliliters of sensitization of every mouse back subcutaneous injection 7%DNCB acetone soln.After the last administration 30 minutes, after attacking 16 hours, 15 milliliters of the DNCB acetone solns of coating same concentrations on every mouse left side auricular concha put to death mouse, take off auricle with the punch tool of 9 mm dias, weigh, make the swelling degree with left and right sides auricle weight difference.Result's (seeing Table 10) finds that notoginseng diol saponin can suppress the tardy property of DNCB inductive mouse contact dermatitis significantly, but effect is not as good as the cortisone of 10 milligrams of/kilogram dosage.Notoginseng diol saponin has significant antagonistic action to the caused VI allergic reaction type of haptens, points out this medicine that the T lymphocyte function is had certain influence.
Table 10 notoginseng diol saponin is to the influence of the tardy property of mouse contact dermatitis
Figure A20041007015600181
*p<0.05 **p<0.01 ***p<0.001
Three, microcirculation of mouse auricle is influenced
40 mouse are used in this test, are divided into 4 groups at random, 10 every group.Male and female half and half.Take out 2 mouse for every group before the administration, (4 * 22) observe the wide capillary vessel number of hits of auris dextra under dissecting microscope, as the microcirculation of mouse auricle normal value, and general 3-4 milligram/kilogram mouse ear.Gastric infusion then, every day 1 time, successive administration 3 days, after the last administration 30 minutes, in the mouse auris dextra capillary vessel number of hits of observing every group.Take the mean and the control group comparison, carry out statistical test, result's (seeing Table 11) finds that notoginseng diol saponin truly has effect promoting blood circulation and removing blood stasis, blood is scarlet, it increases Mice Auricle microcirculation highly significant, but effect is not as good as the FUFANG DANSHEN DIWAN of 5 milligrams of/kilogram dosage, and the function of pseudo-ginseng is a promoting blood circulation and hemostasis, subduing swelling and relieving pain.The test materials that has reported has fully proved the subduing swelling and relieving pain effect of notoginseng diol saponin, also provide experimental basis for treating swelling and ache of bi Zheng clinically in the future, this test is according to " herbal pharmacology experimental technique " the 104th page, select the Mice Auricle microcirculation to observe as the live body microcirculation, found that notoginseng diol saponin also has significant function of promoting blood circulation to disperse blood clots, have the major function of pseudo-ginseng thereby disclosed notoginseng diol saponin.
Table 11 notoginseng diol saponin influences microcirculation of mouse auricle
Figure A20041007015600191
*p<0.05 **p<0.01 ***p<0.001
Conclusion (of pressure testing)
4 kinds of experimental inflammatory models and 2 kinds of analgesic test models are used in this test, carry out main pharmacodynamics research, the anti-inflammatory and analgesic effect that the result proves the notoginseng diol saponin gastric infusion is highly significant all, have disclosed the effect that pseudo-ginseng truly has subduing swelling and relieving pain.Though the pathogeny of rheumatic arthritis and rheumatoid arthritis is still not fully aware of,, our test-results shows that notoginseng diol saponin can treat the scorching disease of rheumatism such as scorching rheumatic arthritis.
The effect highly significant of notoginseng diol saponin anti-experimental character oedema inflammation shows as the restraining effect of the caused mouse dropsy of ear of Oleum Tiglii byer force, and has tangible dose-dependence.In addition, also highly significant of the restraining effect of the swollen or arthroncus of rat foot due to the on Carrageenan, the anti-inflammatory action on these two kinds of models all is not less than INDOMETHACIN.
As everyone knows, rat assist agent arthritis is an immune inflammation model, and its pathogeny is similar to people's rheumatoid arthritis with pathological change.In the different onset stage of this model, the anti-inflammatory action of highly significant all can appear in notoginseng diol saponin, and its action intensity also is not less than INDOMETHACIN.
In addition, notoginseng diol saponin also has tangible anti-inflammatory action to chronic inflammatory diseases, and it shows as rat granuloma swollen restraining effect and hydrocortisone suitable.
The anti-inflammatory action of The above results proof notoginseng diol saponin is strong and scope is wide.
The notoginseng diol saponin oral administration to the analgesic activity of rat and mouse also highly significant, can improve the threshold of pain of warm stimulation, can reduce the caused body number of times of turning round of chemical algogen again.On these 2 kinds of analgesic test models, the notoginseng diol soap to poh mouse analgesic activity not second to INDOMETHACIN, but to the analgesic activity of rat whipping reaction not as INDOMETHACIN, may be through the few reason of medicine number of times according to one's analysis.
Function with reference to pseudo-ginseng cures mainly, and has carried out main pharmacodynamics research around subduing swelling and relieving pain, found that above-mentioned pharmacological action characteristics, provides experimental basis for treating swelling and ache of bi Zheng such as rheumatoid arthritis and rheumatic arthritis clinically.
This test-results is also found the notoginseng diol saponin oral administration, and the mouse T lymphocyte function is had very significantly influence, and microcirculation has to Mice Auricle very significantly increases microcirculatory effect, and the blood inner blood is scarlet in the capillary vessel.The above results further provides foundation for swelling and ache of bi Zheng such as this medicine treatment rheumatic arthritis and rheumatoid Guan Yan.

Claims (8)

1, a kind of preparation method of notoginseng diol saponin is characterized in that comprising the following steps:
A, get pseudo-ginseng and pulverized sieve No. one, add concentration and be 60% alcohol immersion, diacolation, collect percolate;
B, percolate concentrating under reduced pressure reclaim ethanol;
C, concentrated solution dilute with distilled water, slowly are added in the macroporous adsorbent resin separator column, use distilled water, 40% ethanol and 60% ethanol elution successively, collect 60% ethanol eluate;
D, 60% ethanol eluate are 1.10 diol saponin crude product solution through being evaporated to relative density;
E, diol saponin crude product solution are admixed silica gel, abundant mixing, and drying under reduced pressure must be mixed sample silica gel;
F, will mix sample silica gel and pack in 23 times of silicagel columns,, check, and collect and contain ginsenoside R with the silica gel G plate with the mixed solvent wash-out that contains vinyl acetic monomer, second alcohol and water B1, R dStream part Deng composition;
G, elutriant filter, and filtrate decompression is concentrated into phase density 1.33 fluid extracts;
H, fluid extract drying under reduced pressure get dry extract, and dry extract is pulverized, and promptly get the notoginseng diol saponin of light yellowish brown powder.
2, the preparation method of notoginseng diol saponin according to claim 1 is characterized in that the raw material and the ratio of macroporous adsorbent resin are 10: 1.
3, the preparation method of notoginseng diol saponin according to claim 1, the post footpath that it is characterized in that macroporous adsorbent resin with the ratio of post height is: 30: 160.
4, the preparation method of notoginseng diol saponin according to claim 1 is characterized in that described macroporous adsorbent resin is the styrene type interpolymer, and model is D-101.
5, the preparation method of notoginseng diol saponin according to claim 1 is characterized in that described macroporous adsorbent resin separator column is good for handling balance.
6, the preparation method of notoginseng diol saponin according to claim 1, it is characterized in that also comprising used macroporous adsorbent resin separator column is washed with 1% hydrochloride ethanol liquid, reduce the alcohol concn wash-out gradually,, can reuse until extremely neutral with distilled water flushing.
7, the preparation method of notoginseng diol saponin according to claim 1 is characterized in that also comprising that it is colourless to be eluted to effluent liquid with distilled water with used silica gel, the baking of taking-up silica gel, when oven temperature rises to 120 ± 2 ℃, stop heating, naturally cooling can use.
8, the preparation method of notoginseng diol saponin according to claim 1 is characterized in that described concentrating under reduced pressure or drying under reduced pressure temperature are 50 ± 5 ℃.
CN 200410070156 2004-08-04 2004-08-04 Process for preparing notoginseng diol saponin Pending CN1603334A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN 200410070156 CN1603334A (en) 2004-08-04 2004-08-04 Process for preparing notoginseng diol saponin
CNB2005100750390A CN100471865C (en) 2004-08-04 2005-06-08 Process for preparing notoginseng diol saponin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410070156 CN1603334A (en) 2004-08-04 2004-08-04 Process for preparing notoginseng diol saponin

Publications (1)

Publication Number Publication Date
CN1603334A true CN1603334A (en) 2005-04-06

Family

ID=34666788

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410070156 Pending CN1603334A (en) 2004-08-04 2004-08-04 Process for preparing notoginseng diol saponin

Country Status (1)

Country Link
CN (1) CN1603334A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107188910A (en) * 2017-05-24 2017-09-22 云南三七科技有限公司 A kind of preparation method of PDS and panoxadiol type saponin monomer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107188910A (en) * 2017-05-24 2017-09-22 云南三七科技有限公司 A kind of preparation method of PDS and panoxadiol type saponin monomer

Similar Documents

Publication Publication Date Title
CN1836720A (en) Chinese medicine composition for treating arthritis or gout and preparing method thereof
CN1768812A (en) Medicinal composition for removing dampness to relieve itching and its preparation method and uses
CN102824497B (en) Bone rheumatism pain relieving liquid and preparation method thereof
CN102058673B (en) Chinese medicine composition for expelling wind and removing dampness and preparation method thereof
CN1699396A (en) Process for preparing notoginseng diol saponin
CN1927878A (en) Clematis chinensis total saponin and treatment action thereof for rheumatoild disease
CN100344299C (en) Medicine for treating woman's dysmenorrhea and preparing process thereof
CN106265988A (en) A kind of thin medicine moxibustion bar and preparation method thereof
CN1827150A (en) External-use emulsion membrane for treating rheumatism and preparation method thereof
CN1060657C (en) Nourishing medicine for preventing and curing toxic and side effect after tumor radiotherapy and chemotherapy and preparation method
CN1277572C (en) Medicinal composition for treating ulcerative colitis and its preparing method
CN1231239C (en) Medicine for curing hydrocephalus, brain abscess and brain tumor and preparation process thereof
CN101579475A (en) Traditional Chinese medicine for treating eczema
CN1603334A (en) Process for preparing notoginseng diol saponin
CN1186067C (en) Medicine for curing acute injury of muscle and tendon and its preparation method
CN102552724B (en) Chinese medicine composite for curing hypertension
CN1443545A (en) Medicine for curing acne and its preparation method
CN1973850A (en) Medicine composition for treating allergic rhinitis and its prepn process
CN101884664B (en) Medicinal composition for preventing and treating rheumatoid arthritis and preparation method thereof
CN101032540A (en) Medicine composition for curing arthritis and the preparing method and purpose thereof
CN105168306A (en) Pharmaceutical composition for promoting traumatic fracture coalescence
CN101028451A (en) Chinese medicine for treating tic douloureux
CN1248709C (en) Chinese medicine prepn for stopping drug addiction
CN103110700A (en) Fraxinus mandshurica extract for treating rheumatoid arthritis
CN1150918C (en) Medicine containing active components of Panax japonicum root and preparing process thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication